- C.R. Bard (BCR -0.6%), Endo Health (ENDP) and Boston Scientific (BSX +2%) may be set to resolve as many as 50K lawsuits tied to vaginal-mesh implants, people familiar with the matter tell Bloomberg.
- BCR and ENDP have already settled some cases related to the devices. (previous)
- For its part, Johnson & Johnson's (JNJ +0.1%) Ethicon subsidiary is still attempting to wade through the pile of complaints in order to determine which claims have merit and which claims are "unfounded," the company says.